Trial Profile
Multicenter, Randomized, Double Blind, Placebo Controlled Clinical Trial With Riluzole in Spinocerebellar Ataxia Type 2
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Riluzole (Primary)
- Indications Spinocerebellar ataxias
- Focus Therapeutic Use
- Acronyms ATRIL
- 18 Jun 2021 Status changed from recruiting to completed.
- 10 Aug 2018 Planned End Date changed from 1 Nov 2019 to 17 Jan 2019.
- 10 Aug 2018 Planned primary completion date changed from 1 Nov 2019 to 17 Jan 2019.